TaiMed Biologics (4147) — Free Cash Flow Generation Index

Latest as of December 2025: 0.35x

TaiMed Biologics (4147) has a Free Cash Flow Generation Index of 0.35x as of December 2025. Free cash flow of NT$9.20 Million represents 0% of operating cash flow (NT$25.95 Million). See 4147 working capital ratio to evaluate short-term liquidity relative to the company's equity base.

FCF Generation Index

0.35x

Free Cash Flow / Operating CF

Free Cash Flow

NT$9.20 Million

TWD

Operating Cash Flow

NT$25.95 Million

TWD

Capital Expenditures

NT$16.75 Million

TWD

TaiMed Biologics Free Cash Flow Generation Index (2025–2025)

Historical FCF Generation Index trend for TaiMed Biologics across 1 annual periods. Explore TaiMed Biologics (4147) cash flow to debt to assess how comfortably operating cash covers total debt obligations.

Annual Free Cash Flow Generation for TaiMed Biologics (2025–2025)

Year-by-year Free Cash Flow Generation Index for TaiMed Biologics. For the full company profile including market capitalisation, see TaiMed Biologics stock valuation.

Year	FCG Index	Free Cash Flow (TWD)	Operating CF	Capital Expenditures	YoY Change
2025	0.88x	NT$168.38 Million	NT$191.14 Million	NT$22.77 Million	—

FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).